866-997-4948(US-Canada Toll Free)

Platelet-rich Plasma Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Published By :

Transparency Market Research

Published Date : Aug 2018

Category :

Biotechnology

No. of Pages : 265 Pages

Platelet-rich Plasma Market - Overview

This report studies the current as well as future prospects of the global platelet-rich plasma market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of platelet-rich plasma and new entrants planning to enter the market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments considered in the scope of the study. This section also provides the overall information and data analysis of the global platelet-rich plasma market regarding leading segments based on type, origin, application, and region.

The global platelet-rich plasma market has been segmented based on type, origin, application, and region. In terms of type, the global market has been classified into pure platelet-rich plasma, leukocyte-rich platelet-rich plasma, and pure platelet-rich fibrin. Based on origin, the global platelet-rich plasma market has been categorized into autologous platelet-rich plasma, allogeneic platelet-rich plasma, and homologous platelet-rich plasma. In terms of application, the global market has been divided into orthopedic surgery, neurosurgery, cosmetic surgery, general surgery, and others.

The market revenue for each type was estimated using bottom-up approach. The revenue generated by each type and application has been calculated considering sales, usage data, and pattern in different regions. The bottom-up approach for determining the country market size was studied using various market indicators obtained from secondary sources, which include different types and origin of platelet-rich plasma and their cost variations in major country/region; prevalence and incidence in major countries for orthopedic disorders, sports injuries, arthritis, and other major diseases, and other treatments such as cosmetic surgeries and plastic surgeries for which platelet-rich plasma are used. Revenues of all publicly listed market players were obtained through secondary sources and analyzed for platelet-rich plasma systems specific revenues by narrowing down to revenue percentage for product segment through extensive secondary analysis of annual reports, investor presentations, press releases, primary interviews, and others. Data triangulation is based on secondary research (top-down and bottom-up approaches) and primary research. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each segment for the forecast period from 2018 to 2026, considering 2017 as the base year.

The market overview section of the report explores market dynamics such as drivers, restraints, opportunities, and key trends that have a strong impact on the platelet-rich plasma market and could influence it in the near future. Market attractiveness analysis has been provided to explain the intensity of competition across different regions. The competitive scenario among different players is evaluated through market share analysis in the competitive landscape section of the report. These factors are likely to help market players take strategic decisions to strengthen their positions and expand their shares in the global platelet-rich plasma market.

In terms of region, the global platelet-rich plasma market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The report also provides market size and forecast for major countries with each product and distribution channel in the respective region. A detailed qualitative analysis of factors responsible for driving and restraining the market and future opportunities has been provided in the overview section. This section of the report also provides the market attractiveness analysis and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global platelet-rich plasma market.

Major players operating in the global platelet-rich plasma market are Harvest Technologies Corp. (Terumo Corporation), Arthrex, Inc., Zimmer Biomet Holdings, Inc., EmCyte Corporation, Regen Lab SA, Exactech, Inc., and Cesca Therapeutics, Inc., Nuo Therapeutics, Inc., DePuy Synthes (Johnson & Johnson), ISTO Biologics, and AdiStem Ltd.

The global platelet-rich plasma market has been segmented as follows:

Global Platelet-rich Plasma Market, by Type

  • Pure Platelet-rich Plasma
  • Leukocyte-rich Platelet-rich Plasma
  • Pure Platelet-rich Fibrin

Global Platelet-rich Plasma Market, by Origin

  • Autologous Platelet-rich Plasma
  • Allogeneic Platelet-rich Plasma
  • Homologous Platelet-rich Plasma

Global Platelet-rich Plasma Market, by Application

  • Orthopedic Surgery
  • Neurosurgery
  • Cosmetic Surgery
  • General Surgery
  • Others

Global Platelet-rich Plasma Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives

2. Assumptions and Research Methodology

3. Executive Summary : Global Platelet-rich Plasma Market

4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Platelet-rich Plasma Market Analysis and Forecasts, 2016–2026
4.5. Porter’s Five Force Analysis

5. Market Outlook
5.1.Number of Joint Replacement Surgeries, by Key  Countries/Region
5.2.Number of Cosmetic Surgeries, by Key  Countries/Region

6. Global Platelet-rich Plasma Market Analysis and Forecasts, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value  Forecast, by Type, 2016–2026
6.3.1. Pure Platelet-rich Plasma
6.3.2. Leukocyte-rich Platelet-rich Plasma
6.3.3. Pure Platelet-rich Fibrin
6.4. Market Attractiveness, by Type
6.5. Key Trends

7. Global Platelet-rich Plasma Market Analysis and Forecasts, by Origin
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Origin, 2016–2026
7.3.1. Autologous Platelet-rich Plasma
7.3.2. Allogeneic Platelet-rich Plasma
7.3.3. Homologous Platelet-rich Plasma
7.4. Market Attractiveness, by Origin
7.5. Key Trends

8. Global Platelet-rich Plasma Market Analysis and Forecasts, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2016–2026
8.3.1. Orthopedic Surgery
8.3.2. Cosmetic Surgery
8.3.3. General Surgery
8.3.4. Neurosurgery
8.3.5. Others
8.4. Market Attractiveness, by Application
8.5. Key Trends

9. Global Platelet-rich Plasma Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Country/Region

10. North America Platelet-rich Plasma Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2016–2026
10.2.1. Pure Platelet-rich Plasma
10.2.2. Leukocyte-rich Platelet-rich Plasma
10.2.3. Pure Platelet-rich Fibrin
10.3. Market Value Forecast, by Origin, 2016–2026
10.3.1. Autologous Platelet-rich Plasma
10.3.2. Allogeneic Platelet-rich Plasma
10.3.3. Homologous Platelet-rich Plasma
10.4. Market Value Forecast, by Application, 2016–2026
10.4.1. Orthopedic Surgery
10.4.2. Cosmetic Surgery
10.4.3. General Surgery
10.4.4. Neurosurgery
10.4.5. Others
10.5. Market Value Forecast, by Country, 2016–2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Origin
10.6.3. By Application
10.6.4. By Country

11. Europe Platelet-rich Plasma Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by Type, 2016–2026
11.2.1. Pure Platelet-rich Plasma
11.2.2. Leukocyte-rich Platelet-rich Plasma
11.2.3. Pure Platelet-rich Fibrin
11.3.Market Value Forecast, by Origin, 2016–2026
11.3.1. Autologous Platelet-rich Plasma
11.3.2. Allogeneic Platelet-rich Plasma
11.3.3. Homologous Platelet-rich Plasma
11.4.Market Value Forecast, by Application, 2016–2026
11.4.1. Orthopedic Surgery
11.4.2. Cosmetic Surgery
11.4.3. General Surgery
11.4.4. Neurosurgery
11.4.5. Others
11.5.Market Value Forecast, by Country/Sub-region, 2016–2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6.Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Origin
11.6.3. By Application
11.6.4. By Country/Sub-region

12. Asia Pacific Platelet-rich Plasma Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast, by Type, 2016–2026
12.2.1. Pure Platelet-rich Plasma
12.2.2. Leukocyte-rich Platelet-rich Plasma
12.2.3. Pure Platelet-rich Fibrin
12.3.Market Value Forecast, by Origin, 2016–2026
12.3.1. Autologous Platelet-rich Plasma
12.3.2. Allogeneic Platelet-rich Plasma
12.3.3. Homologous Platelet-rich Plasma
12.4.Market Value Forecast, by Application, 2016–2026
12.4.1. Orthopedic Surgery
12.4.2. Cosmetic Surgery
12.4.3. General Surgery
12.4.4. Neurosurgery
12.4.5. Others
12.5.Market Value Forecast, by Country/Sub-region, 2016–2026
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of APAC
12.6.Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Origin
12.6.3. By Application
12.6.4. By Country/Sub-region

13. Latin America Platelet-rich Plasma Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value Forecast, by Type, 2016–2026
13.2.1. Pure Platelet-rich Plasma
13.2.2. Leukocyte-rich Platelet-rich Plasma
13.2.3. Pure Platelet-rich Fibrin
13.3.Market Value Forecast, by Origin, 2016–2026
13.3.1. Autologous Platelet-rich Plasma
13.3.2. Allogeneic Platelet-rich Plasma
13.3.3. Homologous Platelet-rich Plasma
13.4.Market Value Forecast, by Application, 2016–2026
13.4.1. Orthopedic Surgery
13.4.2. Cosmetic Surgery
13.4.3. General Surgery
13.4.4. Neurosurgery
13.4.5. Others
13.5.Market Value Forecast, by Country/Sub-region, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of LATAM
13.6.Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Origin
13.6.3. By Application
13.6.4. By Country/Sub-region

14. Middle East & Africa Platelet-rich Plasma Market Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2.Market Value Forecast, by Type, 2016–2026
14.2.1. Pure Platelet-rich Plasma
14.2.2. Leukocyte-rich Platelet-rich Plasma
14.2.3. Pure Platelet-rich Fibrin
14.3.Market Value Forecast, by Origin, 2016–2026
14.3.1. Autologous Platelet-rich Plasma
14.3.2. Allogeneic Platelet-rich Plasma
14.3.3. Homologous Platelet-rich Plasma
14.4.Market Value Forecast, by Application, 2016–2026
14.4.1. Orthopedic Surgery
14.4.2. Cosmetic Surgery
14.4.3. General Surgery
14.4.4. Neurosurgery
14.4.5. Others
14.5.Market Value Forecast, by Country/Sub-region, 2016–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6.Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Origin
14.6.3. By Application
14.6.4. By Country/Sub-region

15. Competition Landscape
15.1.Market Player – Competition Matrix (By Tier and Size of companies)
15.2.Market Share Analysis, by Company (2017)
15.3. Company Profiles
15.3.1. Zimmer Biomet Holdings, Inc.

  • Company Overview (HQ, Business Segments, Employee Strength)
  • Product Portfolio
  • SWOT Analysis
  • Strategic Overview

15.3.2. AdiStem Ltd.

  • Company Overview (HQ, Business Segments, Employee Strength)
  • Product Portfolio
  • SWOT Analysis
  • Strategic Overview

15.3.3. ISTO Biologics

  • Company Overview (HQ, Business Segments, Employee Strength)
  • Product Portfolio
  • SWOT Analysis
  • Financial Overview
  • Strategic Overview

15.3.4. Cesca Therapeutics, Inc.

  • Company Overview (HQ, Business Segments, Employee Strength)
  • Product Portfolio
  • SWOT Analysis
  • Financial Overview
  • Strategic Overview

15.3.5. Stryker Corporation

  • Company Overview (HQ, Business Segments, Employee Strength)
  • Product Portfolio
  • SWOT Analysis
  • Financial Overview
  • Strategic Overview

15.3.6. DePuy Synthes

  • Company Overview (HQ, Business Segments, Employee Strength)
  • Product Portfolio
  • SWOT Analysis
  • Financial Overview
  • Strategic Overview

15.3.7. Arthrex, Inc.

  • Company Overview (HQ, Business Segments, Employee Strength)
  • Product Portfolio
  • SWOT Analysis
  • Financial Overview
  • Strategic Overview

15.3.8. Harvest Technologies Corp. (Terumo Corporation)

  • Company Overview (HQ, Business Segments, Employee Strength)
  • Product Portfolio
  • SWOT Analysis
  • Financial Overview
  • Strategic Overview

15.3.9. Regen Lab SA

  • Company Overview (HQ, Business Segments, Employee Strength)
  • Product Portfolio
  • SWOT Analysis
  • Financial Overview
  • Strategic Overview

15.3.10. EmCyte Corporation

  • Company Overview (HQ, Business Segments, Employee Strength)
  • Product Portfolio
  • SWOT Analysis
  • Financial Overview
  • Strategic Overview

15.3.11. Exactech, Inc.

  • Company Overview (HQ, Business Segments, Employee Strength)
  • Product Portfolio
  • SWOT Analysis
  • Financial Overview
  • Strategic Overview

15.3.12. Nuo Therapeutics, Inc.

  • Company Overview (HQ, Business Segments, Employee Strength)
  • Product Portfolio
  • SWOT Analysis
  • Financial Overview
  • Strategic Overview

List of Table

Table 01: Global Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 02: Global Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Origin, 2016–2026
Table 03: Global Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 04: Global Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 05: North America Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 06: North America Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 07: North America Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Origin, 2016–2026
Table 08: North America Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 09: U.S. Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 10: U.S. Platelet-rich Plasma Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 11: U.S. Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 12: Canada Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 13: Canada Platelet-rich Plasma Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 14: Canada Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 15: Europe Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 16: Europe Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 17: Europe Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Origin, 2016–2026
Table 18: Europe Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 19: Germany Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 20: Germany Platelet-rich Plasma Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 21: Germany Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 22: U.K. Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 23: U.K. Platelet-rich Plasma Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 24: U.K. Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 25: France Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 26: France Platelet-rich Plasma Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 27: France Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 28: Italy Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 29: Italy Platelet-rich Plasma Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 30: Italy Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 31: Spain Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 32: Spain Platelet-rich Plasma Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 33: Spain Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 34: Asia Pacific Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 35: Asia Pacific Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 36: Asia Pacific Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Origin, 2016–2026
Table 37: Asia Pacific Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 38: China Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 39: China Platelet-rich Plasma Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 40: China Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 41: India Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 42: India Platelet-rich Plasma Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 43: India Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 44: Japan Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 45: Japan Platelet-rich Plasma Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 46: Japan Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 47: Australia & New Zealand Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 48: Australia & New Zealand Platelet-rich Plasma Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 49: Australia & New Zealand Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 50: Latin America Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 51: Latin America Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 52: Latin America Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Origin, 2016–2026
Table 53: Latin America Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 54: Brazil Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 55: Brazil Platelet-rich Plasma Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 56: Brazil Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 57: Mexico Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 58: Mexico Platelet-rich Plasma Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 59: Mexico Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 60: Middle East & Africa Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 61: Middle East & Africa Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 62: Middle East & Africa Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Origin, 2016–2026
Table 63: Middle East & Africa Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 64: GCC Countries Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 65: GCC Countries Platelet-rich Plasma Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 66: GCC Countries Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 67: South Africa Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 68: South Africa Platelet-rich Plasma Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 69: South Africa Platelet-rich Plasma Market Size (US$ Mn) Forecast, by Application, 2016–2026

List of Chart

Figure 01: Global Platelet-rich Plasma Market Size (US$ Mn) Forecast, 2016–2026
Figure 02: Global Platelet-rich Plasma Market Value Share Analysis, by Type, 2017 and 2026
Figure 03: Global Platelet-rich Plasma Market Revenue
Figure 04: Global Platelet-rich Plasma Market Revenue (US$ Mn), by Leukocyte-Rich Platelet-rich Plasma, 2016–2026
Figure 05: Global Platelet-rich Plasma Market Revenue
Figure 06: Global Platelet-rich Plasma Market Attractiveness
Figure 07: Global Platelet-rich Plasma Market Value Share Analysis, by Origin, 2017 and 2026
Figure 08: Global Platelet-rich Plasma Market Revenue (US$ Mn), by Autologous Platelet-rich Plasma, 2016–2026
Figure 09: Global Platelet-rich Plasma Market Revenue (US$ Mn), by Allogenic Platelet-rich Plasma, 2016–2026
Figure 10: Global Platelet-rich Plasma Market Revenue
Figure 11: Global Platelet-rich Plasma Market Attractiveness Analysis, by Origin, 2018–2024 
Figure 12: Global Platelet-rich Plasma Market Value Share Analysis, by Application, 2017 and 2026
Figure 13: Global Platelet-rich Plasma Market Revenue (US$ Mn), by Orthopedic Surgery, 2016–2026
Figure 14: Global Platelet-rich Plasma Market Revenue (US$ Mn), by Cosmetic Surgery, 2016–2026
Figure 15: Global Platelet-rich Plasma Market Revenue (US$ Mn), by General Surgery, 2016–2026
Figure 16: Global Platelet-rich Plasma Market Revenue (US$ Mn), by Neurosurgery, 2016–2026
Figure 17: Global Platelet-rich Plasma Market Revenue (US$ Mn), by Other Surgeries, 2016–2026
Figure 18: Global Platelet-rich Plasma Market Attractiveness Analysis, by Application, 2018–2026
Figure 19: Global Platelet-rich Plasma Market Value Share Analysis, by Region, 2017 and 2026
Figure 20: Global Platelet-rich Plasma Market Attractiveness Analysis, by Region, 2018–2026
Figure 21: North America Platelet-rich Plasma Market Size (US$ Mn) Forecast, 2016–2026
Figure 22: North America Platelet-rich Plasma Market Attractiveness Analysis, by Country, 2018–2026
Figure 23: North America Platelet-rich Plasma Market Value Share Analysis, by Country, 2017 and 2026
Figure 24: North America Platelet-rich Plasma Market Value Share Analysis, by Type, 2017 and 2026
Figure 25: North America Platelet-rich Plasma Market Value Share Analysis by Origin, 2017 and 2026
Figure 26: North America Platelet-rich Plasma Market Value Share Analysis, by Application, 2017 and 2026
Figure 27: North America Platelet-rich Plasma Market Attractiveness Analysis, by Types, 2018–2026
Figure 28: North America Platelet-rich Plasma Market Attractiveness Analysis, by Origin, 2018–2026
Figure 29: North America Platelet-rich Plasma Market Attractiveness Analysis, by Application, 2018–2026
Figure 30: Europe Platelet-rich Plasma Market Size (US$ Mn) Forecast, 2016–2026
Figure 31: Europe Platelet-rich Plasma Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 32: Europe Platelet-rich Plasma Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 33: Europe Platelet-rich Plasma Market Value Share Analysis, by Type, 2017 and 2026
Figure 34: Europe Platelet-rich Plasma Market Value Share Analysis, by Origin, 2017 and 2026
Figure 35: Europe Platelet-rich Plasma Market Value Share Analysis, by Application, 2017 and 2026
Figure 36: Europe Platelet-rich Plasma Market Attractiveness Analysis, by Type, 2018–2026
Figure 37: Europe Platelet-rich Plasma Market Attractiveness Analysis, by Origin 2018–2026
Figure 38: Europe Platelet-rich Plasma Market Attractiveness Analysis, by Application, 2018–2026
Figure 39: Asia Pacific Platelet-rich Plasma Market Size (US$ Mn) Forecast, 2016–2026
Figure 40: Asia Pacific Platelet-rich Plasma Market Attractiveness Analysis, by Country/Sub-Region, 2018–2026
Figure 41: Asia Pacific Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 42: Asia Pacific Platelet-rich Plasma Market Value Share Analysis, by Type, 2017 and 2026
Figure 43: Asia Pacific Platelet-rich Plasma Market Value Share Analysis, by Origin, 2017 and 2026
Figure 44: Asia Pacific Platelet-rich Plasma Market Value Share Analysis, by Application, 2017 and 2026
Figure 45: Asia Pacific Platelet-rich Plasma Market Attractiveness Analysis, by Type, 2018–2026
Figure 46: Asia Pacific Platelet-rich Plasma Market Attractiveness Analysis, by Origin, 2018–2026
Figure 47: Asia Pacific Platelet-rich Plasma Market Attractiveness Analysis, by Application, 2018–2026
Figure 48: Latin America Platelet-rich Plasma Market Size (US$ Mn) Forecast, 2016–2026
Figure 49: Latin America Platelet-rich Plasma Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 50: Latin America Platelet-rich Plasma Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 51: Latin America Platelet-rich Plasma Market Value Share Analysis, by Type, 2017 and 2026
Figure 52: Latin America Platelet-rich Plasma Market Value Share Analysis, by Origin, 2017 and 2026
Figure 53: Latin America Platelet-rich Plasma Market Value Share Analysis, by Application, 2017 and 2026
Figure 54: Latin America Platelet-rich Plasma Market Attractiveness Analysis, by Type, 2018–2026
Figure 55: Latin America Platelet-rich Plasma Market Attractiveness Analysis, by Origin, 2018–2026
Figure 56: Latin America Platelet-rich Plasma Market Attractiveness Analysis, by Application, 2018–2026
Figure 57: Middle East & Africa Platelet-rich Plasma Market Size (US$ Mn) Forecast, 2016–2026
Figure 58: Middle East & Africa Platelet-rich Plasma Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 59: Middle East & Africa Platelet-rich Plasma Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 60: Middle East & Africa Platelet-rich Plasma Market Value Share Analysis, by Type, 2017 and 2026
Figure 61: Middle East & Africa Platelet-rich Plasma Market Value Share Analysis, by Origin, 2017 and 2026
Figure 62: Middle East & Africa Platelet-rich Plasma Market Value Share Analysis, by Application, 2017 and 2026
Figure 63: Middle East & Africa Platelet-rich Plasma Market Attractiveness Analysis, by Type, 2018–2026
Figure 64: Middle East & Africa Platelet-rich Plasma Market Attractiveness Analysis, by Origin, 2018–2026
Figure 65: Middle East & Africa Platelet-rich Plasma Market Attractiveness Analysis, by Applications, 2018–2026
Figure 66: Global Platelet-Rich Plasma Market Share Analysis, by Company, (2017)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *